Mandate

Vinge has represented Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB

Vinge has represented the leading infrastructure group Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB from Vestum. These companies are engaged in contracting activities within the construction sector. The total purchase price for the shares amounts to 747 MSEK. All key executives in the companies will become shareholders in Eleda.

Hanell Entreprenad i Gävle AB and FlexiRail AB both have extensive experience in railway maintenance, and Eleda also strengthens its leading position in ground construction in Stockholm through the acquisition of Marbit Aktiebolag.

The transaction is subject to regulatory approvals, and the closing is expected to occur in the first quarter of 2025.

Vinge's team primarily consisted of Christina Kokko, Johanna Wiberg, Eléonore Friberg, Madelene Andersson, and Chris Bastholm (M&A), Niclas Lindblom (Construction), Sara Franson (Real Estate), Hanna Kövamees (Commercial Agreements), Siri Bromberg (GDPR), Calle Tengwall Pagels and William Carlberg Johansson (Banking and Finance), Simon Söderholm and Jessica Jacob (Employment Law), Hayaat Ibrahim and Gulestan Ali (Compliance), Marcus Glader, Daniel Wendelsson, Dagne Sabockis, Lovisa Lewin, and Lovisa Arpi (Competition Law and FDI), and Jasmina Skandrani (Project Assistant).

Read the client's press release here.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025